The company's average rating is Hold from 1 analysts. We provide trade advice to complement the prevailing
expert consensus on BIO Key International. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available today.
The successful prediction of BIO Key
stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published
stock prices of traded companies, such as BIO Key International, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at
the intrinsic value of BIO Key based on BIO Key hews, social hype, general headline patterns, and widely used
predictive technical indicators. We also calculate exposure to BIO Key's
market risk, different
technical and
fundamental indicators, relevant financial multiples and ratios, and then
comparing them to BIO Key's related companies.
Use Technical Analysis to project BIO expected Price
BIO Key technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of BIO Key technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of BIO Key trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions.
More Info...BIO Key Gross Profit
BIO Key Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing BIO Key previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show BIO Key Gross Profit growth over the last 10 years. Please check BIO Key's
gross profit and other
fundamental indicators for more details.
Details
The current price rise of BIO Key International could raise concerns from stockholders as the firm closed today at a share price of
0.71 on
12,569,101 in volume. The company management teams may have good odds in positioning the firm resources to exploit market volatility in
September. The stock standard deviation of daily returns for 30 days investing horizon is currently 9.36. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the BIO Key partners.
Deferred Revenue Breakdown
BIO Key Deferred Revenue is decreasing over the last several years with very volatile swings. Deferred Revenue is estimated to finish at about 429.2
K this year. Deferred Revenue usually refers to a component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue; including sales; license fees; and royalties; but excluding interest income. BIO Key Deferred Revenue is most likely to decrease significantly in the upcoming years. The last year's value of Deferred Revenue was reported at 359,212
| 2013 | 528,160 |
| 2014 | 429,233 |
| 2015 | 376,405 |
| 2016 | 633,062 |
| 2017 | 507,866 |
| 2018 | 196,609 |
| 2019 | 359,212 |
| 2020 | 429,228 |
Chances of BIO Key to rebound
The maximum drawdown is down to 78.74 as of today. BIO Key International is showing large volatility of returns over the selected time horizon. We encourage all investors to investigate this asset further to make sure related market timing strategies are aligned with all the expectations about BIO Key implied risk. BIO Key International is a potential penny stock. Although BIO Key may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in BIO Key International. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
Our Takeaway on BIO Key Investment
While few other entities in the security & protection services industry are either recovering or due for a correction, BIO Key may not be performing as strong as the other in terms of long-term growth potentials. With a less-than optimistic outlook for your 30 days horizon, it may be a good time to short some or all of your BIO Key holdings as it seems the potential growth was already fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to BIO Key.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of BIO Key International. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
